HCPCS code J3375 — Inj vancomycin (xellia) 10mg.
Status: Active.
Effective Jul 1, 2025.
Source: CMS HCPCS Level II.
J3375
ActiveInj vancomycin (xellia) 10mg
Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jul 1, 2025
Code type:
alphanumeric
OPPS Status:
N
— Items / services packaged into APC rates
MUE — Medically Unlikely Edits
Maximum units of J3375 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 600 |
| Outpatient Hospital | 600 |
| Practitioner Services | 600 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 70594-0041-03 | Vancomycin HCl |
| 70594-0042-03 | Vancomycin HCl |
| 70594-0043-02 | Vancomycin HCl |
| 70594-0044-02 | Vancomycin HCl |
| 70594-0056-03 | Vancomycin HCl |
| 70594-0057-02 | Vancomycin HCl |
| 70594-0058-02 | Vancomycin HCl |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2025-Q3Inj vancomycin (xellia) 10mg